Inogen Inc. Files 8-K on Financials
Ticker: INGN · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1294133
| Field | Detail |
|---|---|
| Company | Inogen Inc (INGN) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: INGN
TL;DR
Inogen filed an 8-K on 2/25/25 for financial updates.
AI Summary
On February 25, 2025, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing indicates Inogen Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- Inogen Inc. (company) — Registrant
- February 25, 2025 (date) — Date of Report
- 859 Ward Drive, Goleta, California 93111 (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but the specific details are not provided in the excerpt.
When was this 8-K report filed?
The report was filed on February 25, 2025.
What is Inogen Inc.'s principal executive office address?
Inogen Inc.'s principal executive offices are located at 859 Ward Drive, Goleta, California 93111.
What is the Commission File Number for Inogen Inc.?
The Commission File Number for Inogen Inc. is 001-36309.
What is the SIC code for Inogen Inc.?
The Standard Industrial Classification (SIC) code for Inogen Inc. is 3842, which corresponds to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding Inogen Inc (INGN).